Mr. Schinecker, currently serving as Roche’s head of centralized and point-of-care solutions, will succeed Michael Heurer, who is retiring at the end of July.
Mr. Heurer had been serving as interim CEO of the $13 billion diagnostics unit, which includes diabetes care and personalized cancer treatments.
Roche also announced that Peter Voser will leave Roche’s board of directors by July.
More articles on pharmacy:
Sanofi poaches exec from Novartis
Eli Lilly’s migraine drug 1st approved to reduce cluster headaches: 4 notes
EpiPen shortage will drag on: 4 things to know
